Synopsis of recent research by authors named "Shih-Hsun Kuo"
- Shih-Hsun Kuo's recent research predominantly focuses on the development of novel therapeutic strategies for treating aggressive cancers, particularly glioblastoma and colorectal cancer, highlighting the importance of understanding molecular mechanisms and resistance in cancer therapies.
- His studies have revealed potential therapeutic agents, such as Arylquin 1 for glioblastoma and XPF-ERCC1 blockers in colorectal cancer, emphasizing their roles in enhancing treatment efficacy and overcoming resistance associated with conventional chemoradiotherapy.
- Kuo's work also investigates critical biomarkers, including Nucleobindin-2 and SPINK1, which influence tumor progression and treatment response, providing valuable insights that could inform precision medicine approaches in oncology.
